Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions. (Q48660910)
Jump to navigation
Jump to search
scientific article published on 26 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions. |
scientific article published on 26 July 2011 |
Statements
1 reference
Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions. (English)
1 reference
Herman Nilsson-Ehle
1 reference
Gunnar Birgegård
1 reference
Jan Samuelsson
1 reference
Petar Antunovic
1 reference
Jan Astermark
1 reference
Hege Garelius
1 reference
Lena M Engström
1 reference
Lars Kjeldsen
1 reference
Lars Nilsson
1 reference
Anna Olsson
1 reference
Mette Skov-Holm
1 reference
Jonas Wallvik
1 reference
Nina Gulbrandsen
1 reference
Eva Hellström-Lindberg
1 reference
26 July 2011
1 reference
1 reference
87
1 reference
244-252
1 reference
3
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference